Aeterna Zentaris to Announce Second Quarter 2012 Financial and Operating Results on August 14, 2012
QUEBEC CITY, Aug. 8, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2012 financial and operating results after market close on Tuesday, August 14, 2012. The Company will host a conference call on the following day, Wednesday, August 15, 2012, at 8:30 a.m. (Eastern Time), to discuss these results, provide an update on the Company's business and discuss expectations for the future.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information, please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
More by this Source
Aeterna Zentaris Announces Election of Directors at its Annual Meeting of Shareholders
May 08, 2013, 16:05 ET
Aeterna Zentaris Reports First Quarter 2013 Financial and Operating Results
May 07, 2013, 16:44 ET
Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013
May 01, 2013, 07:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.